Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension

Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes

(2013) Alexandra Scholze et al.   Cardiovascular Diabetology

Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study

(2013) Esben Laugesen et al.   Cardiovascular Diabetology

Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?

(2013) S. B. Bender et al.   DIABETES

Long-term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome

(2013) Verena Drüppel et al.   FASEB JOURNAL

Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus

(2013) Christina S. Oxlund et al.   JOURNAL OF HYPERTENSION

Diagnosis and Treatment of Erectile Dysfunction for Reduction of Cardiovascular Risk

(2013) Ajay Nehra et al.   JOURNAL OF UROLOGY

Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension

(2012) H. Shibata et al.   AMERICAN JOURNAL OF HYPERTENSION

Determinants of vascular function in patients with type 2 diabetes

(2012) Katerina K Naka et al.   Cardiovascular Diabetology

Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes

(2012) Vibe Skov et al.   Cardiovascular Diabetology

Diabetes and hypertension: the bad companions

(2012) Ele Ferrannini et al.   LANCET

Erectile Dysfunction and Hypertension: Impact on Cardiovascular Risk and Treatment

(2012) Valter Javaroni et al.   International Journal of Hypertension

Fibulin-1 Is a Marker for Arterial Extracellular Matrix Alterations in Type 2 Diabetes

(2011) C. Cangemi et al.   CLINICAL CHEMISTRY

Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)

(2011) Jan Václavík et al.   HYPERTENSION

Renin-Angiotensin-Aldosterone System in Diabetes and Hypertension

(2011) Willa A. Hsueh et al.   Journal of Clinical Hypertension

Pulse pressure and systolic night–day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus

(2011) E Laugesen et al.   JOURNAL OF HUMAN HYPERTENSION

Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease

(2010) Rhonda M. Cooper-DeHoff et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction

(2009) Istvan Kovanecz et al.   BJU INTERNATIONAL

Resistant Hypertension: Diagnosis, Evaluation, and Treatment

(2008) David A. Calhoun et al.   CIRCULATION

Fibulin-1 is required for morphogenesis of neural crest-derived structures

(2008) Marion A. Cooley et al.   DEVELOPMENTAL BIOLOGY